Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile
NCT01470339
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Pain
Interventions
DRUG:
duloxetine
Sponsor
Rambam Health Care Campus